Skip to content
Saturday 22 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,816.56
+0.64%
DAX
26,136.56
+0.59%
CAC 40
8,484.43
+0.37%
STOXX 50
6,462.22
+0.63%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 15 April 2020 3:09 pm  |  Updated:  Wednesday 15 April 2020 3:11 pm

Tilney and Smith & Williamson merger delayed by coronavirus crisis

By: James Booth

Add as a preferred source on Google
The FTSE 100 opened higher this morning after global stocks hit record highs on the back of the US Federal Reserve's pledge to keep interest rates near zero.

The merger between Tilney and Smith & Williamson has been delayed by the coronavirus pandemic with significant doubts remaining as to whether it will go ahead.

Smith & Williamson shareholder AGF Management told the Toronto Stock Exchange today that the deal would continue with a revised structure with the targeted closing date pushed back until the second half of the year.

However, AGF said it was not certain the deal would go ahead.

“While all parties remain committed to the merger, given the covid-19 situation and the fact that the revised structure has not yet been agreed, there can be no certainty that the transaction will proceed,” the statement said.

Morning Wire reported last month that the coronavirus pandemic and the ensuing economic crisis had left the deal on the brink.

Wealth manager Tilney – which is backed by private equity firm Permira – announced in September it had agreed to acquire wealth manager and accountancy firm Smith & Williamson in a £625m deal.

AGF said the two businesses had extended the original expiry date of the merger (16 April) to agree a new transaction structure intended to meet final regulatory approval.

The Financial Conduct Authority was reportedly concerned that the combined business would carry too much debt under the original transaction structure.

AGF said: “Significant progress has been made toward a revised transaction structure, including a material new equity investment and thus a significant reduction in the external debt levels of the post-completion combined group.”

The two sides expect to confirm if agreement has been reached by the end of May.

Read more

Astrazeneca share price tumbles on $400bn megamerger talks

Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure

The new structure would require approval from regulatory and competition authorities and Smith & Williamson shareholders.

If the deal does go ahead, it would be expected to complete in the second half of the year.

David Cobb and Kevin Stopps, co-chief executives of Smith & Williamson, said: “We continue to believe in the compelling strategic rationale of this merger and are pleased to report that significant progress has been made towards revisions to Tilney’s transaction structure that address the points raised by the FCA.

“However, in light of the extraordinary circumstances created by the covid-19 pandemic, the transaction process has inevitably been delayed.

“If the parties can agree amendments to the transaction structure that the Smith & Williamson board is able to recommend, we will ask our shareholders to vote on whether the revised transaction should go ahead.”

In September when the deal was announced, the pair said the combined business would have an enterprise value of £1.8bn, with revenue of around £500m and profit of £150m.

Tilney agreed to buy out Smith & Williamson shareholders with consideration of £625m, through a combination of cash and shares in the combined group.

In 2017 Smith & Williamson held an unsuccessful round of merger talks with wealth manager Rathbones.

Tilney launched an alternative bid, but Smith & Williamson chose instead to pursue a deal with Rathbones that ultimately collapsed.

Read more

Astrazeneca explores $400bn megadeal with US rival 

AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Categories

  • Legal

Related Topics

  • M&A

Trending Articles

  • House prices in wealthy London boroughs fall by up to £300,000

  • As it happened: Miners fuel FTSE 100 recovery; oil jumps as Trump claims Strait of Hormuz

  • City law firm sues prominent Emirati business family

  • Amanda Blanc has worked her magic at Aviva

  • As it happened: FTSE 100 rallies after JD Sports drags on blue chips; oil jumps again

More from Morning Wire

  • Astrazeneca share price tumbles on $400bn megamerger talks

    Investing
    Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure
  • Astrazeneca explores $400bn megadeal with US rival 

    Markets
    AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.
  • Competition watchdog clears Paramount Warner Bros acquisition

    Media
    Paramount, Netflix, Warner logos; media giants intensifying streaming competition and strategic industry shifts
  • UK economy’s rebound fails to stem two years of mass job losses 

    Economics
    LONDON, UNITED KINGDOM - JANUARY 31: The Shard is seen on the horizon as commuters cross London Bridge during the morning rush hour on January 31, 2023 in London, United Kingdom. The IMF reports that the UK economy will contract by 0.6% in 2023, as opposed to the previous prediction it might grow, and will perform worse than many other advanced economies, including Russia.The cost of living continues to hit households with grocery inflation for the first four weeks of 2023 rising to 16.7% which would add a further £788 per year to family food bills. (Photo by Leon Neal/Getty Images)
  • Paramount-Warner Bros deal faces ‘sufficient competition’, says CMA

    Media
    Paramount, Netflix, Warner logos; media giants intensifying streaming competition and strategic industry shifts
  • Amanda Blanc has worked her magic at Aviva

    Insurance
    Aviva's deal to buy Direct Line was agreed in March
  • Cavendish taps top adviser to fend off foreign takeover interest

    Advisory
    St Pauls Cathedral in London, framed by modern glass buildings under a clear sky, near Cavendishs base
  • Private equity-backed advisory firm acquires specialist music boutique

    Advisory
    Nowadays, headliners are less of a major part of the festival experience
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook